Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Dayeon Yun; Hyun-Ouk Kim; Hye Young Son; Yuna Choi; Ilkoo Noh; Jong-Woo Lim; Jihye Kim; Haejin Chun; Geunseon Park; Dong Ki Lee; Sung Il Jang; Eunji Jang; Yong-Min Huh; Seungjoo Haam

doi:10.1039/C7TB90158E

Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Dayeon Yun,^a Hyun-Ouk Kim,^a Hye Young Son,^b Yuna Choi,^b Ilkoo Noh,^c Jong-Woo Lim,^a Jihye Kim,^a Haejin Chun,^a Geunseon Park,^a Dong Ki Lee,^d Sung Il Jang,^d Eunji Jang,^b Yong-Min Huh*^b and Seungjoo Haam*^a

Author affiliations

* Corresponding authors

^a Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 120-749, Republic of Korea
E-mail: haam@yonsei.ac.kr

^b Department of Radiology, Yonsei University, Seoul 120-752, Republic of Korea
E-mail: ymhuh@yuhs.ac

^c Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejon 305-701, Republic of Korea

^d Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-Gu, Seoul 135-720, Republic of Korea

Abstract

Correction for ‘Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy’ by Dayeon Yun et al., J. Mater. Chem. B, 2017, 5, 6317–6324.

Journal of Materials Chemistry B

Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy

Social activity

Search articles by author

Spotlight

Advertisements